UBS Group AG's third-quarter 2026 report arrives as the bank enters the final stretch of its multi-year integration of Credit Suisse, acquired in 2023. This earnings event matters because it offers investors a progress check on cost savings, capital returns, and the health of its core wealth-management franchise. A year earlier, net profit attributable to shareholders stood at $2.48 billion, so the latest figure of $2.69 billion reflects continued year-over-year growth. With elevated macroeconomic volatility, geopolitical tensions, and political uncertainty weighing on investor sentiment, the quarter also signals how effectively UBS can sustain client momentum and defend its balance sheet heading into 2027.
For the third quarter ended September 30, 2026, UBS reported net profit attributable to shareholders of $2.69 billion, up 8% from $2.48 billion a year earlier, with diluted earnings per share (EPS) of $0.85. Reported pre-tax profit reached $3.59 billion, while underlying pre-tax profit rose 14% to $4.08 billion. Total revenues increased 5% to $13.35 billion, or 10% on an underlying basis to $13.39 billion.
The cost/income ratio was 72.3% on a reported basis and 68.7% underlying. Return on Common Equity Tier 1 (CET1) capital was 14.8% reported and 16.7% underlying. Global Wealth Management pre-tax profit rose 11% to $1.92 billion, supported by $55.1 billion in net new assets, while Personal & Corporate Banking posted its best result in seven quarters. Reported results were broadly in line with expectations, with underlying revenues and pre-tax profit exceeding consensus estimates. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Investor reaction to UBS's third-quarter 2026 results centered on the strength of its underlying profitability and the accelerating completion of the Credit Suisse integration. Net profit came in slightly below some headline estimates, but adjusted operating income and adjusted pre-tax profit exceeded the AWP consensus, according to UBS. The market also focused on robust wealth-management inflows of $55.1 billion and a record Investment Bank quarter, which helped offset lingering concerns around proposed Swiss capital requirements and ongoing AT1 litigation. Management's confirmation that it expects to end 2026 with a CET1 capital ratio at or very close to its roughly 14% target reinforced confidence in continued shareholder distributions.
UBS enters the fourth quarter with the Credit Suisse integration in its "last mile." Management said nearly all legacy applications are no longer in use, with around 90% fully decommissioned, and expects the integration to be substantially complete by year-end. Investors should watch whether the bank delivers the additional roughly $0.5 billion of gross cost savings it has guided for the fourth quarter, which would bring total savings to about $13.7 billion and exceed the original $13.5 billion ambition.
On capital returns, UBS has repurchased $4.8 billion of shares year to date and accrued $2.8 billion for dividends. It intends to repurchase a further $1.2 billion over the next three months to complete its current $3 billion program, with 2027 capital return ambitions to be announced alongside fourth-quarter results in February 2027.
Finally, investors should monitor the evolving Swiss regulatory debate over higher capital requirements and the resolution of AT1 litigation, both of which could influence UBS's balance-sheet flexibility and future buyback capacity. Seasonal softness in transaction volumes and continued macroeconomic uncertainty remain key variables heading into the final quarter.
In my day-to-day research, Tickeron’s AI Screener has become a reliable way to quickly filter stocks and ETFs by technical patterns, fundamentals, and AI-driven signals. It helps me compare names like UBS against peers without spending hours on manual screens, and I often use it to spot potential setups or confirm trends before digging deeper into earnings reports.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
UBS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 27 of 35 cases where UBS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 77%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where UBS's RSI Indicator exited the oversold zone, 19 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for UBS just turned positive on October 12, 2026. Looking at past instances where UBS's MACD turned positive, the stock continued to rise in 27 of 40 cases over the following month. The odds of a continued upward trend are 68%.
Following a +0.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where UBS advanced for three days, in 228 of 345 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UBS as a result. In 55 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UBS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
The Aroon Indicator for UBS entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 5 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 12 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 21, placing this stock better than average.
The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.607) is normal, around the industry mean (1.515). P/E Ratio (15.291) is within average values for comparable stocks, (11.735). Projected Growth (PEG Ratio) (0.669) is also within normal values, averaging (2.139). UBS's Dividend Yield (0.094) is considerably higher than the industry average of (0.035). P/S Ratio (3.209) is also within normal values, averaging (3.867).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating fairly steady price growth. UBS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 72 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks